Önemli: Bu içerik kişisel tıbbi değerlendirme ve muayenenin yerine geçmez. Acil durumlarda önce doktor veya acil servise başvurun — 112.
Tests & Procedures
Holep
What is HoLEP, which patients may benefit, how is it performed, and what are its advantages and risks? A guide to holmium laser prostate surgery for BPH.
HoLEP is an endoscopic laser procedure used to relieve difficulty urinating caused by benign enlargement of the prostate. The goal is to remove excess prostate tissue by entering through the urinary passage without making a skin incision; however, this is not the first choice for every enlarged prostate, and careful patient selection matters. [1][2][3]
What does HoLEP actually mean?
HoLEP is short for “Holmium Laser Enucleation of the Prostate.” Its main purpose is to separate and remove the inner prostate tissue that obstructs urinary flow because of benign prostatic enlargement. The procedure is performed using a closed, endoscopic approach, meaning that no abdominal incision is needed. Using instruments passed through the urethra, the surgeon reaches the prostate tissue, dissects the enlarged tissue away from the prostatic capsule with the laser, pushes it into the bladder, and then fragments and removes it with a special device. [1][2][5]
This technique may be considered in some patients who experience frequent urination, waking at night to urinate, a weak stream, the feeling of incomplete emptying, straining to void, or recurrent urinary retention because of prostate enlargement. Surgical options are generally considered when medication has not provided enough benefit or when complications have developed. HoLEP is one such option and is especially notable because it can also be used in larger prostates. [1][3][4]
Who may be a suitable candidate?
HoLEP is most commonly considered in men with lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH). Markedly reduced urinary flow, incomplete bladder emptying, frequent infections, bladder stones, recurrent urinary blockage, or obstruction severe enough to affect kidney function can all increase the likelihood that surgery will be needed. The decision is driven less by prostate size alone than by the functional problems caused by the enlargement. [1][3][4]
HoLEP is not recommended automatically for every patient. For some people, medication may be sufficient; for others, different minimally invasive procedures or more conventional surgical options may be more appropriate. Age, use of blood thinners, prostate size, bladder function, neurological status, and surgical expectations are all evaluated together. A urologist should not decide on the procedure before confirming that the symptoms are truly due to BPH. [1][3][4]
How is the preoperative assessment performed?
Before HoLEP, the severity of symptoms, prostate size, and the degree of urinary flow impairment are assessed. This may involve physical examination, appropriate laboratory tests such as PSA, urinalysis, ultrasound, uroflowmetry, and when needed cystoscopy or urodynamic studies. The goal is to confirm that the problem requiring treatment is indeed prostate-related obstruction. Weak bladder muscle function or neurological disease can produce similar complaints. [1][3][4]
If there is a urinary tract infection before surgery, it is treated first. Current medications are reviewed, and bleeding risk is assessed. It is also important to inform the patient beforehand about temporary catheter use, blood in the urine after the procedure, and possible symptoms during the recovery period. Good patient education reduces anxiety after surgery and makes expectations more realistic. [1][4][5]
How is HoLEP performed?
During the procedure, the surgeon enters through the urethra and uses a holmium laser to separate the enlarged inner part of the prostate from the prostatic capsule. The tissue is then moved into the bladder and removed after being fragmented using a technique called morcellation. In this way, the tissue narrowing the urinary stream is cleared. Compared with open surgery, the fact that it is less invasive, does not require an external incision, and can be used in large prostates are among its key advantages. [1][2][5]
After surgery, most patients have a temporary urinary catheter. The duration of catheterisation and the length of hospital stay vary depending on the centre, the patient’s overall condition, and the amount of postoperative bleeding. Some centres offer a short stay, but this is not identical for every patient. The primary goal is to relieve urinary obstruction while supporting a safe recovery. [1][2][5]
What are the advantages and limitations?
One of the major advantages of HoLEP is that it can be an effective option regardless of prostate size. In addition, because it uses laser technology, bleeding control may be better in some patients, and the removed tissue can be sent for pathological examination, which offers a diagnostic benefit. Even so, not every “closed” procedure is automatically the best option for everyone; surgeon experience and the infrastructure of the treatment centre can have a substantial impact on results. [1][2][3]
One of the most important practical limitations of this technique is its steep learning curve. In other words, HoLEP is a technically demanding procedure that requires experience. Some patients may also continue to experience irritative urinary symptoms for a period after surgery. For that reason, the decision should be based not on the word “laser” alone, but on centre experience, alternatives, and personal treatment goals. [1][3][5]
Risks and side effects
After HoLEP, temporary burning with urination, urgency, blood in the urine, transient leakage-type incontinence, or short-term irritative symptoms may occur. Less commonly, urethral stricture, bladder neck narrowing, infection, or the need for repeat intervention may develop. Retrograde ejaculation, in which semen flows backward into the bladder instead of exiting through the urethra, is another important outcome that may occur after BPH surgery and should be discussed in advance. [1][2][5]
Severe pain while urinating, blockage from large clots, fever, inability to pass urine, or rapidly increasing bleeding may fall outside the expected course of recovery. In such cases, medical evaluation should not be delayed. Especially in the first weeks after surgery, adequate fluid intake, avoiding heavy lifting, and following the physician’s instructions all support recovery. [1][4][5]
Recovery and return to daily life
In many patients, improvement in urinary flow is noticed relatively early after HoLEP; however, because the bladder has often been responding to obstruction for years, it may take time for symptoms to settle completely. Urgency and frequency may persist in the first days, but this does not always mean the surgery has failed. The bladder may simply need time to adapt. [1][4][5]
The time needed to return to daily life varies from person to person. During the early period, the timeframe given by the doctor regarding strenuous exercise, physically demanding work, and sexual activity should be followed. If symptoms of urinary tract infection, persistent burning, or a recurrent sense of blockage develop, re-evaluation is important. In an appropriate patient, a successful HoLEP can reduce the need for medication and substantially improve quality of life; however, individual outcomes can never be guaranteed in advance. [1][3][4]
When should you see a doctor?
A urological evaluation should not be postponed in the presence of severe straining to urinate, complete urinary retention, recurrent urinary tract infections, frequent blood in the urine, declining kidney function, or bladder stones. After surgery, high fever, heavy bleeding with clots, severe pain, or inability to pass urine require urgent assessment. [1][4][5]
HoLEP can be an effective treatment option for BPH, but the most critical parts of the process are choosing the right patient, performing an appropriate urological evaluation, and discussing personal expectations openly. Treatment decisions should be based not only on prostate volume, but also on symptom severity and the patient’s overall health. [1][3][4]
References
- 1.Mayo Clinic. Holmium laser prostate surgery. 2025. https://www.mayoclinic.org/tests-procedures/holmium-laser-prostate-surgery/about/pac-20384871
- 2.Mayo Clinic. Prostate laser surgery. 2023. https://www.mayoclinic.org/tests-procedures/prostate-laser-surgery/about/pac-20384874
- 3.European Association of Urology (EAU). Management of Non-neurogenic Male LUTS. https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/chapter/disease-management
- 4.NIDDK. Enlarged Prostate (Benign Prostatic Hyperplasia). 2025. https://www.niddk.nih.gov/health-information/urologic-diseases/prostate-problems/enlarged-prostate-benign-prostatic-hyperplasia
- 5.Royal Free London NHS Foundation Trust. Holmium laser enucleation of the prostate (HoLEP). 2024. https://www.royalfree.nhs.uk/patients-and-visitors/patient-information-leaflets/holmium-laser-enucleation-of-the-prostate-holep
